Adverse drug reactions to trimethoprim-sulfamethoxazole in systemic lupus erythematosus.

Shinji IzukaHiroyuki YamashitaYuko TakahashiHiroshi Kaneko

Published in: Lupus (2021)

Patients with SLE who are prophylactically administered TMP-SMX are at high risk of ADRs. Among these patients, those who display a positive anti-Sm antibody should be carefully monitored for ADRs.

Keyphrases

adverse drug
end stage renal disease
ejection fraction
systemic lupus erythematosus
newly diagnosed
chronic kidney disease
emergency department
rheumatoid arthritis
wastewater treatment